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SUMMARY
Multilocus enzyme electrophoresis was used to divide 124 Australian isolates of
Streptococcus suts type 2 into 17 electrophoretic types (ETs). Isolates in ET 1 were
the most frequent cause ofdisease amongst Western Australian pigs, but isolates
of ET 8 were more commonly associated with disease in other Australian states.
Multiple isolates from 10 of 19 farms all belonged to the same ET, whilst isolates
from the other farms belonged to between 2 and 4 different ETs. Some isolates
could be differentiated further by DNA restriction endonuclease analysis, whilst
others with the same restriction pattern were located in different, but closely-
related ETs. Fourteen isolates were tested for their virulence in mice. Most caused
disease ifgiven in high numbers, but isolates in ET 1 were virulent at lower dose
rates. This virulent clone also was distinguished by the fact that 80% of isolates
produced extracellular factor (EF).
INTRODUCTION
Streptococcus suis can cause a variety of clinical problems in young pigs,
especially meningitis, pneumonia, septicaemia and arthritis [1-3]. The bacterial
species has been divided into 29 capsular serotypes, designated 1 to 28, and type
1/2 [4-6]. Of these, serotype 2 is the most important causing disease in pigs in
most parts ofthe world [7, 8], although serotype 7 predominates in Scandinavia
[6, 9]. Despite the association of these bacteria with disease, they may also be
recovered from the nasal cavities and tonsils of healthy pigs [10-12].
Outbreaks ofdisease may follow periods ofstress, such as when weaned pigs are
moved and mixed, or are overcrowded. The build-up of fumes from slurry,
combined with poor ventilation, also predisposes to disease [13]. Outbreaks also
may occur following the introduction of new pigs to a herd [14]. It is presumed
that these are healthy carrier animals which bring new virulent strains into the
herd, and that these strains then spread to susceptible pigs. Strains ofS. suis type
2 with differing degrees ofvirulence to pigs have been described [14, 15]. Virulent
strains produced a muramidase-released protein (MRP) and, particularly, an
extracellular factor (EF) [16, 17]. Strains thatproduced a higher molecularweight
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form ofEF (EF*) were ofintermediate virulence in newborngerm-free pigs, whilst
strains lacking both proteins did not induce any signs of disease [17].
The species S. suis is genetically homogeneous as assessed by levels of DNA
sequence homology between 13 strains [18]. The use of multilocus enzyme
electrophoresis (MEE) to examine a much larger collection of S. suis isolates of
various serotypes has, however, shown the species to berelatively diverse [19]. For
instance 31 isolates ofserotype 2 had a mean genetic diversity of0-264, and were
divided into 6 electrophoretic types (ETs), representing 3 clonal groups. Genetic
differences between strains of S. suis type 2 also have been demonstrated using
DNA restriction endonuclease analysis (REA), and ribotyping with anEscherichia
coli rDNA probe [20, 21]. These techniques have also been used to study the
distribution of strains of the bacteria amongst pigs during outbreaks of S. suis-
associated disease.
The purpose ofthis study was to determine the diversity ofWestern Australian
(WA) isolates ofS. suis type 2, and the association ofspecific strains with clinical
problems on piggeries. MEE was used as it is applicable to studies of bacterial
populations [22], and is a useful technique for analysing isolates of S. suis [19].
Results were comparedwith those previously obtainedfor otherAustralian strains
ofS. suis type 2 [19]. In addition REA was used to help clarify the epidemiology
ofthe infections. The virulence ofisolates in different genetic groups was assayed
in mice, and correlated with the presence or absence ofMRP and EF in Western
blot analysis of culture supernatants, using specific monoclonal antisera.
MATERIALS AND METHODS
Bacterial isolates
The isolates of S. suis type 2 (n = 124) were from 4 main sources (Table 1).
Source 1 comprised 67 isolates collected during a survey ofpigs from 19 Western
Australian (WA) piggeries (designated A to S respectively). The isolates were from
the tonsils or lungs of healthy pigs following their slaughter at local abattoirs,
except for 2 isolates from farm S which were obtained by swabbing the nasal
cavities of 2 healthy grower pigs. Between 2 and 5 isolates were examined from
slaughtered pigs from each herd, with an average of 3-4 isolates per herd. Source
2 comprised 15 isolates recovered from 6 litter-mates on farm Q. These animals
were followed as a cohort from weaning to slaughter, with nasal swabs taken from
each pig at 1, 2, 3 and 4 months ofage, and swabs from the nose, tonsils and lungs
taken following slaughter at 6 months. Source 3 comprised 11 isolates from WA
pigs clinically affected with streptococcal meningitis. These were received from
N. B. Buller of the Veterinary Diagnostic Microbiology Laboratory, WA
Department of Agriculture, South Perth, or were isolated from dead pigs
submitted for diagnosis to the Murdoch University Veterinary Hospital. These
animals came from 4 farms (R to U respectively). The 4th source was 31 strains
ofS. suis type 2 studied previously [19], and included isolates from pigs in South
Australia (n = 22), Tasmania (n = 3), Victoria (n = 2), and New South Wales
(n = 2). Seventeen were from pigs with meningitis or septicaemia, and 12 were
isolated from the tonsils ofhealthy animals atslaughter. One isolate was recovered
in Australia from the meninges ofa human, and the other was a porcine reference
strain from the State Serum Institute, Copenhagen, Denmark.Analysis of Streptococcus suis type 2
Table 1. Electrophoretic types of Streptococcus suis type 2 isolatedfrom
Australian pigs
Electrophoretic
type WA piggeries* Other statest
1 G(3); 1(3); J(3); L(1); SA(1); SA(1)T
M(2); N(3); R(3); R(6)$;
S(2)$; U(1)$
2 TAS(1)t
3 Q(3)
4 C(2)
5 S(1)
6 TAS(1)T; NSW(2)$
7 Q(1); R(2) SA(6); SA(2)T
8 A(3); C(1); D(3); E(3); SA(4); SA(7$);
F(3); H(3); L(2); P(3); TAS(1)$; VIC(2)$
Q(14); T(1)T
9 M(3)
10 B(3); L(1)
11 H(1) SA(1)
12 K(2); R(1)T
13 K(1); O(1)
14 O(1)
15 S(2)
16 S(3)
17 S(2)
* Twenty-one piggeries in WNestern Australia, designated A to IU. Numbers in parentheses are
the number of isolates.
t SA. South Australia. TAS, Tasmania. NSW, New South Wales, VIC, Victoria.
i Indicates isolates recovered from pigs with disease. All the other isolates are from healthy
pigs. ET 1 also contained an isolate from a human with meningitis, and ET 2 contained a Danish
porcine reference strain.
Bacterial isolation and characterization
Swabs were taken from the live and the slaughtered pigs as described previously
[23]. These were used to inoculate medium incorporating 3 9% (w/v) Columbia
agar base (Oxoid), 1-5% (w/v) streptococcal selective antibiotic supplement
(Oxoid), and 5% (v/v) specific sheep antiserum raised against a South Australian
reference strain of S. suis type 2 [24]. Plates were incubated aerobically for
18-24 h at 37 °C, and then for 24 h at 4 'C. Colonies ofS. suis type 2 were identified
by the presence ofbright broad haloes ofimmunoprecipitation around them when
viewed by indirect light in semi-darkness [25, 26]. Specificity of the method was
confirmed by testing representatives of each batch of plates with S. suis isolates
ofserotypes 1, 3-9, 13, 15, 18, 20, and untypable isolates ofS. suis [19], as well as
with Enterococcus faecalis, S. pyogenes, S. equi, S. zooepidemicus, S. bovis, and a
group G streptococcus.
Positive colonies were subcultured to (i) Columbia agar containing 5 % (v/v)
defibrinated ovine blood (SBA plates), and incubated overnight at 37 'C, and (ii)
the selective agar, which in this case contained specific sheep antiserum to S. suis
type 1. Colonies that reacted positively on both antiserum plates were recorded as
being type 1/2, and were not investigated further.
Small alpha-haemolytic colonies of Gram positive cocci growing on the SBA
plates were confirmed as being S. suis by testing for absence of growth on 6-5%
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Fig. 1. Phenogram of genetic distance (expressed as percent fixed allelic differences)
among 17 ETs, containing 124 isolates ofS. suis type 2, clustered by the unweighted
pair group method with averages (UPGMA) strategy.
NaCl agar, a negative Voges-Proskauer test, and production of acid in either
trehalose or salicin broths or both [27]. The serotype ofselected isolates from each
of the major genetic groups was subsequently confirmed using the tube
precipitation and/or the capsular swelling reaction tests [27].
Multilocus enzyme electrophoresis (MEE)
The technique has been described [19]. Briefly, bacterial cells were grown
overnight in 500 ml of Todd-Hewitt broth (Oxoid), harvested by centrifugation,
washed in phosphate buffered saline (PBS; pH 7 2), centrifuged again, and
resuspended in sonication buffer (40 mM-K2HPO4, 10 mM-L-cysteine HCl, 5 jtg/ml
bovine serum albumen, 3 mm dithiothrietol, pH 7 5). They were lysed by four
cycles of sonication, clarified by centrifugation, and the supernatant collected.
These lysates were subjected to electrophoresis in 11F4% horizontal starch gels,
and the electrophoretic mobilities ofthe following 16 enzymes were determined by
staining for specific enzyme activity: Leucyl-tyrosine peptidase (LT), glucose-6-
phosphate dehydrogenase (G6P), mannose-6-phosphate isomerase (MPI), leucyl-
glycine peptidase (LGG), nucleoside phosphorylase-1 (NP), a-naphthyl esterase
(EST), leucyl-proline peptidase (LP), glutamate dehydrogenase (GDH), phospho-
glucomutase (PGM), lactate dehydrogenase (LDH), 6-phosphogluconate de-
hydrogenase (6PG), nucleoside phosphorylase-2 (NSP), adenylate kinase (ADK),
glyceraldehyde-3-phosphate dehydrogenase (GI1), alanine dehydrogenase (ALD),
and phosphoglucose isomerase (PGI). The gel and electrode buffers used were tris-
citrate (pH 8-0).
Mobility variants of the enzymes were interpreted as the products of different
alleles at the corresponding enzyme locus. Groups ofone of more isolates with the
same alleles at all loci were referred to as being an electrophoretic type (ET).
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Table 2. DNA restriction endonuclease analysis (REA) patterns of 33 Australian
isolates of S. suis type 2 belonging to different electrophoretic types (ETs)
Health REA
Isolates* statust ETI pattern§
S9, S10, U1 d 1 1
R1-R3 h 1 2
R6-R11 d 1 3
C4-5 (SA) d 8 4
F2 h 8 5
F1, F3 h 8 6
N3 h 8 7
13 (TAS) d 2 8
St h 5 9
S2, S3 h 15 10
S4-S6 h 16 10
S7, S8 h 17 10
R4, R5 h 7 11
C7-32 (SA) h 7 12
BI h 10 13
R12 d 12 14
01 h 13 14
02 h 14 14
* TAS, Tasmania; SA, South Australia. All the other isolates originated from Western
Australia.
t d, diseased pig; h, healthy pig.
t ETs in MEE analysis, shown in Fig. 1.
§ Followingdigestion withHaeIIJ. Patterns were not obtained for53 otherisolatesexamined.
Geneticdiversity (h) ateachenzyme locus was calculated ash = (1-XPi2)(n/n- 1),
where Pi is the frequency of the ith allele and n is the number of ETs or isolates
in the sample [28]. Total genetic diversity (H) was calculated as the mean ofh over
all loci. Genetic distances between ETs were calculated as the proportion of fixed
loci at which dissimilar alleles occurred, and the unweighted pair-group method of
arithmetic averages (UPGMA) clustering fusion strategy was used to create a
phenogram (Fig. 1) to show relationships between isolates [29].
DNA restriction endonuclease analysis (REA)
REA was based on techniques described for S. suis [20, 21]. Attempts were
made to obtain DNA banding patterns from 83 of the WA isolates, and 3 other
Australian isolates (Table 2). The bacteria were grown overnight in 100 ml
Todd-Hewitt broth, harvested by centrifugation at 10000 g, and washed twice in
PBS (pH 7 2). The pellet was resuspended in 750jdl of 250 mM-Tris HCl, pH 8-0,
containing 10jug/ml freshly prepared lysozyme, and was incubated at 37 °C for
1 h, with occasional shaking. The tube was centrifuged at 15000 g for 3 min, the
supernatant removed, and the pellet resuspended in 750#1 of TE buffer (50 mM-
Tris, 10 mM-EDTA, pH 8 0). The tube was frozen at -20 °C, thawed, and 150/ul
of pre-warmed STEP buffer (0 5% SDS, 50 mM-Tris HCl, pH 7-5, 40 mM-EDTA)
added, followed by proteinase K to a concentration of 1 mg/ml. The tube was
mixed by inversion and incubated at 50 °C for 1 h. 500jul of phenol-chloroform
was added and the tube repeatedly mixed by gentle inversion until an emulsion
formed. Following centrifugation at 5000 g for 5 min, the upper aqueous layer was
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removed andre-extracted withphenol-chloroform. After centrifugation, the upper
aqueous layer was transferred to a new tube, and 901ul of3 M sodium acetate and
I ml ofisopropanol added. After mixing, the DNA was spooled out, rinsed briefly
in 70% ethanol, dried, and dissolved in 250,1 ofTE buffer. The concentration of
the dissolved DNA was determined by measuring absorbance at 260 nm [30].
15 ,tg DNA was then digested with 20 units ofHaeIII (Boehringer Mannheim) in
10% medium salt buffer for 6 h at 37 'C. Digested DNA was subjected to
electrophoresis for 21 h at 30 V in horizontal 0-7% agarose gels using TBE
electrophoresis buffer (45 mM-Tris borate, 1 mM-EDTA, pH 8-0). Phage lambda
DNA predigested withHindIII andHindIII+EcoR1 (Boehringer Mannheim) was
used as a molecular mass marker. Gels were stained by soaking in ethidium
bromide (0'5 mg/ml), and were photographed under u.v. light. Where distinct
banding patterns could not be obtained after 2-5 attempts, isolates were recorded
as being not susceptible to digestion with HaeIII. DNA banding patterns were
assessed visually without knowledge of results obtained by other methods.
Characteristic patterns were given a numeral, and DNAs with similar patterns
were subjected to electrophoresis on the same gel to check for differences.
Virulence testing
Three-week-old outbred female Swiss ARC Albino SPF mice (Animal Resources
Centre, Perth, Western Australia) were used to test the virulence of 14 selected
isolates (the first 14 isolates in Table 3). This procedure was approved by the
Murdoch University Animals Experimentation and Ethics Committee, and was
monitored by the University's Animal Welfare Officer.
Six ofthe isolates were recovered from clinical cases ofS. suis type 2 infections
in pigs, and 8 were recovered from healthy pigs at slaughter. Eight ofthe isolates
tested belonged to ET 1, 4 to ET 8, and 2 to ET 12 (Fig. 1). The mice were housed
in 14 groups of 7, in individual mouse boxes. Six mice were inoculated initially
with 2 x 108 colony forming units (c.f.u.), which had been resuspended from early
log-phase culture in Todd-Hewitt broth into 0 1 ml of sterile PBS, by the
intraperitoneal route; the 7th mouse acted as an in-contact control. One week
later the surviving animals were challenged with 4 x 108 c.f.u. of the same strain
in 0-2 ml PBS, and a week later survivors were challenged with 1 x 109 c.f.u. in a
0 5 mlvolume. Surviving mice werekilled 1 weeklater, and swabs weretaken from
the heart blood and cultured for S. suis type 2. Throughout the experiment the
mice were observed twice daily, and any clinical signs recorded.
Analysisfor MRP and EF production
The production of muramidase-release protein (MRP) and extracellular factor
(EF) by the 14 isolates tested for virulence in mice, and another 17 isolates (Table
3), was assayed [16, 17]. Overnight cultures in Todd-Hewitt broth were diluted
1:10 in fresh broth, and incubated at 37 'C for 4 h. The cultures were centrifuged
at 4000 g for 15 min, and the supernatants analysed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 8% separating gels,
andbyWestern immunoblotting, using a mini-Protean IIelectrophoresis unit and
transblot cell (Bio-Rad Laboratories, Richmond, Calif.). A control culture
supernatant from a Dutch strain, 4005,which was positive for MRP and EF, andAnalysis of Streptococcus suis type 2
Table 3. Production of muramidase release protein (MRP) and extracellularfactor
(EF) by 31 isolates S. suis type 2
Isolate*
S9
S10
U1
R6
I1
LI
Ni
Ji
D2
E2
Q5V4
Ti
Kl
R12
C5-16 (SA)II
13 (TAS)
C5
DR31-V3
15 (TAS)
C7-25 (SA)
D7-42 (SA)
04
B3
C8-39 (SA)
C6-13 (SA)
14 (TAS)
C4-5 (SA)
Q6
Qi
DR41-4
DR27-T
Statust
d
d
d
d
h
h
h
h
h
h
h
d
h
d
d
d
h
h
d
h
d
h
h
h
d
d
d
h
h
h
h
ETt
1
1
1
1
1
1
1
1
8
8
8
8
12
12
1
2
4
5
6
7
7
9
10
8
8
8
8
13
14
15
16
MRP§
+
+
+
EF§
+ +
+
* The first 14 isolates (S9-R12)) were tested for virulence in mice, and S9, Ul, I1, LI and Ni
caused disease at 2 x 108 c.f.u. when administered intraperitoneally. SA, South Australia; TAS,
Tasmania. All other isolates from Western Australia.
t Disease status ofpig from which the isolate was recovered. d, diseased; h, healthy.
t ET, electrophoretic type in Fig. 1.
§ +, protein present in the supernatant; -, protein absent; x , higher molecular mass band
present (EF*).
11 Isolate from a case of meningitis in a human.
which was supplied by DrUriVecht, DLO-Central Veterinary Institute, Lelystad,
The Netherlands, was also included on the gels. Following electrophoresis, gels
were stained using a silver staining kit (Bio-Rad Laboratories). Proteins that
transferred to nitrocellulose membranes in Western blots were blocked for 1 h in
5% (w/v) non-fat milk powder, and then incubated with a 1: 1 mixture of mouse
anti-MRPmonoclonalantibody (Mab) (113 mg/ml) andanti-EFMab (8-4 mg/ml),
each in a 1:200 dilution [16, 17], provided by Dr Vecht. After washing, the
membranes were incubated with a 1:2000 dilution of a 1:1 mixture ofgoat anti-
mouseIgG andgoat anti-mouse IgM, both conjugatedwithhorseradishperoxidase
(Bio-Rad laboratories). After washing, antibodies were localized by adding the
12-2
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substrate 3-3'-diaminobenzidine tetrahydrochloride dihydrate (Bio-Rad
Laboratories).
RESULTS
MEE
The enzymes LDH, ADK, GP1 and ALD were monomorphic whilst the other
12 enzymes were polymorphic, with 2-4 alleles. The average number ofalleles per
locus was 2-69. The 124 isolates were divided into 17 ETs, with a mean genetic
diversity per locus of0 397, or 0-283 when the number ofisolates in each ET was
considered. Two broad genetic diversions were observed (Fig. 1). ETs 1-11
contained 111 (89-5%) ofthe 124 isolates, separated from ETs 12-17 at a genetic
distance of 0-467.
The WA isolates were distributed in 15 ofthe ETs, but not in ETs 2 or 6 (Table
1). The Danish isolate and the other Australian isolates of serotype 2, from our
previous study [19], were located in ETs 1, 2, 6, 7, 8 and 11. These ETs
corresponded respectively to ETs 33, 34, 50, 51, 53 and 54 in our previous study
[19]. Overall, there were 50 isolates in ET 8. ET 1 contained 30 isolates, ET 7 11
isolates, and the other ETs between 1 and 4 isolates.
Isolates in ET 8 were common in WA (39% ofisolates), where they made up 35
ofthe 82 (43%) isolates from healthy pigs, but only 1 ofthe 11 (9%) isolates from
diseased animals. Isolates in this ET also were common in the other states (14 of
29 porcine isolates; 47%), but here they were more frequently recovered from
diseased pigs (10 of 17; 59%) than from healthy animals (4 of 12; 33%). In
contrast, isolates in ET 1 were common inWA (29% of93 isolates), but were much
less so in the other states (2 of29; 7%). In WA they made up 82% (9 of 11) ofthe
clinical isolates, but only 22% (18 of 82) of those from healthy pigs.
Isolates were collected from healthy pigs on 19 farms, and on 11 of these all
belonged to the same ET. Five farms had isolates belonging to 2 ETs, 2-3 ETs,
whilst the 8 isolates from farm S belonged to 4 ETs. In the cohort study on farm
Q, 9 isolates from 5 of 6 pigs belonged to ET 8 (as did 3 isolates collected earlier
in the abattoir survey). In the sixth pig, however, 2 isolates were of ET 8, 3 ET
3, and 1 ET 7. Ofthe 11 isolates recovered from diseased pigs in WA (Table 1), 9
belonged to ET 1, and 1 each to ETs 8 and 12. Isolates belonging to these ETs were
also recovered from healthy WA pigs. The 17 isolates from diseased pigs in other
Australian states belonged to ETs 1(1), 2(1), 6(3), 7(2) and 8(10); those from
healthy pigs were of ETs 1(1), 7(6), 8(4) and 11(1) (Table 1).
REA
Fourteen different REA patterns (Fig. 2) were identified for 33 isolates, using
the enzyme HaeIII (Table 2). Patterns could not be obtained for 53 other isolates
as these either failed to lyse adequately, yielded poor quality DNA, or the DNA
was refractory to HaeIII.
The 12 belonging to ET 1 in MEE analysis were divided into three REA
patterns. Notably, 3 nasal isolates from healthy pigs on farm R had a different
patternfrom 6 clinical isolates from diseasedpigs on the same property. The latter
had an additional band at approximately 22 kb. Five isolates belonging to ET 8
were divided into 4 REA patterns. In contrast 7 isolates, from farm S, all had
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Fig. 2. Restriction fragment patterns of DNA from isolates ofS. suis type 2. Samples
digested with HaeJII and separated by electrophoresis in 07% agarose. Fourteen
patterns were recognized, and representative isolates from each of these are presented
in ascending order in lanes 2-8, and 10-16. Lanes: 1 and 9, A DNA size markers; 2,
isolate S9; 3, isolate RI; 4, isolate R6; 5, isolate C4-5 (SA); 6, isolate F2; 7, isolate F3;
8, isolate L3; 10, isolate 13 (TAS); 11, isolate SI; 12, isolate S5; 13, isolate R4; 14,
isolate C7-32 (SA); 15, isolate Bi; 16, isolate R12.
REA pattern No. 10, but were separated by MEE into the closely related ETs 15,
16 and 17. Similarly, another 3 isolates with REA pattern No. 14 belonged to the
closely related ETs 12, 13 and 14.
Virulence testing
Following the first challenge, some mice (mean 1P7 of6) inoculated with isolates
Ut, It and LI died, and S. suis type 2 was isolated from these. Other mice
inoculated with these cultures, as well as S9 and NI, also developed clinical signsC. G. MWANIKI AND OTHERS
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Fig. 3. Western blots ofcell culture supernatants ofthe 14 isolates ofS. suis type 2 that
were used to infect mice. Membranes probed with a 1:1 mixture of mouse anti-MRP
and anti-EF Mab (supplied by U. Vecht). Lane 1, positive control supernatant
(MRP+ve; EF+ve), supplied byU. Vecht; Lane 2, isolate S9; lane 3, isolate S10; lane
4, isolate Ul; lane 5, isolate R6; lane 6, isolate I1; lane 7; isolate LI; lane 8, isolate
NI; lane 9, isolate J1; lanes 10 and 11, prestained molecular mass markers (low range,
Bio-Rad Laboratories); lane 12, isolate D; lane 13, isolate E2; lane 14, isolate Q5V4;
lane 15, isolate T1; lane 16, isolate K; lane 17, isolate R 12; lane 18, positive control
supernatant.
(10 of25 mice), which included lack ofgrooming, lethargy and incoordination. All
five isolates belonged to ET 1, although only S9 and Ul originated from diseased
pigs. Following the second challenge, with a higher inoculum, only those mice
exposed to isolate LI developed disease. Two ofthese 4 animals died, and the other
2 showed clinical signs. After the 3rd inoculation, deaths occurred in 12 of the 14
groups, although not in mice challenged with isolates S9 or Ki. Forty-one of 77
mice died (53%), and 23 showed clinical signs (30%).
MRP and EF production
Production of MRP and EF by the 31 isolates is recorded in Table 3. Specific
bands in Western blots using the Mabs are shown in Fig. 3 for the 14 isolates tested
for virulence in mice. Three phenotypes were recorded: MRP and EF positive;
330
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MRP positive, EF negative; MRP and EF negative. Isolates from diseased
animals were more likely to produce MRP and EF than were those from healthy
animals. Isolate C5-16 (SA), from a human with meningitis, had an EF protein
with a molecular mass of approximately 150 kDa (EF*; membrane not shown).
DISCUSSION
MEE indicated that S. suis type 2 from healthy and diseased Australian pigs
originated from diverse genetic backgrounds, confirming the conclusions ofothers
that serotyping cannot be relied upon for strain identification ofS. suis [20, 31].
Two broad genetic groups were identified. The smaller group comprised 13 isolates
(10O5%) in 6 ETs, and included only 1 ofthe 28 isolates from diseased pigs. This
group is, therefore, probably of minor significance clinically.
Despite the overall diversity amongst isolates, 40, 24 and 9% belonged to ETs
8, 1 and 7 respectively. The geographical distribution ofETs 1 and 8 in Australia
differed, as did their association with disease. ET 1 was the most common cause
of disease in WA, and ET 8 in South Australia, Tasmania and Victoria. Isolates
from both ETs were also recovered from healthy pigs on farms without a history
ofrecurrent S. suis type 2-associated disease. Some isolates in ETs 2, 6, 7 and 12
were also associated with disease, indicating that virulence is not restricted to the
two most common ETS (1 and 8).
The distribution ofstrains ofS. suis type 2 varied on different farms, and more
than one ET was found in 9 of 19 (47%) WA piggeries. On the other 10 properties
all isolates were of the same ET, although some of these (ETs, 1, 8, 10, 13) were
found on other properties, indicating that these strains may be widespread.
To determine whether isolates within an ET were likely to be identical,
attempts were made to differentiate them using REA. This proved possible for
only a proportion ofisolates and it is possible that differences in the thickness or
composition of the capsule could have accounted for variations in cell lysis, and
recovery of DNA. Nevertheless, using REA, it was possible to detect differences
between certain isolates in ETs 1, 8 and 7, including those from the same farms,
e.g. ETs 1 and 8 on farms R and F respectively. Those in ET 1, from farm R, were
particularly interesting because isolates from healthy pigs (pattern 2) differed
from isolates from diseased animals (pattern 3; Fig. 2). The latter had an
additional DNA band (approximately 22 kb) that might have been associated
with virulence. Unfortunately these isolates were lost following a freezer failure,
and could not be investigated further. Other isolates from different but closely
related ETs gave the same REA pattern (patterns 10 and 14). All isolates with
pattern 10 were from the same farm, but comprised three related ETs (ETs 15, 16
and 17). The significance of these minor differences is uncertain.
In order to assess the relationship between genetic group and virulence, 14
isolates, from ETs 1, 8 and 12, were tested in mice. Mice were chosen because they
are a convenient model ofS. suis type 2 infection inpigs [32, 33], eventhough their
use has never been fully compared with standardized pig models of the disease.
Intraperitoneal injection also has been found to be an easy and effective route for
establishing infection in mice [32, 34]. Most isolates belonging to ET 1 were more
virulent in mice than are those in ETs 8 or 12, although most isolates were capable
of inducing disease at higher dose rates. It was unclear why isolate S9 causedC. G. MWANIKI AND OTHERS
disease at 2 x 101 c.f.u., but not following challenge with 1 x 109 c.f.u. A protective
immunity may have developed after the mice received the initial doses, but a
similar effect was not seen with other isolates. Three ofthe 5 most virulent isolates
were recovered from the tonsils ofhealthy pigs at slaughter, showing that healthy
pigs may harbour virulent strains.
Vecht and colleagues [16, 17] demonstrated that isolates of S. suis type 2,
virulent to newborn germ-free pigs, released MRP and EF into the culture
medium. Isolates that produced both MRP and EF*, a higher molecular weight
form of EF, were of intermediate virulence, whilst isolates not producing either
form did not induce disease. In this study, 8 ofthe isolatesproduced MRP, but not
EF or EF*; this phenotype has not previously been described. Six isolates from
ET 1 tested in mice produced both MRP and EF, and, in concordance with results
obtained in pigs [16, 17], 4 were virulent at relatively low doses. Nevertheless
isolate II, also in ETI, did not produce MRP or EF, but was virulent at low dose
rates. Other isolates, lacking either or both proteins, were virulent at higher dose
rates. MRP and EF, therefore, are not essential as virulence determinants in mice
inoculated by the intraperitoneal route. They may be important in the early
establishment of infection in natural cases of disease in pigs, however, since 6 of
13 isolates from diseased pigs produced MRP and EF, and 4 produced MRP,
whilst only 2 of 18 isolates from healthy pigs produced MRP and EF, and 4
produced MRP. Although most isolates from healthy pigs were MRP and EF
negative, some that were potentially more virulent (MRP and EF positive) were
carried by healthy animals in certain of the WA herds that infrequently suffer
from S. suis-associated disease. The absence of disease in these herds may be
associated with superior management practices, such as provision of good
ventilation and low stocking densities.
Isolate C5-16 (SA) recovered from the meninges of a human produced an EF-
like molecule (EF*) with a higher molecular mass than that produced by our
porcine isolates (approximately 150 kDa, compared to 110 kDa). Similar material
(EF*) has been described by Vecht and colleagues [17] in strains isolated from
humans, although in relatively few porcine isolates. These results suggest that
EF* may be involved in specific aspects of the pathogenesis of the infection in
humans.
All the isolates producing EF belonged to the closely related ETs 1 and 2 (8 of
10 isolates analysed from these ETs were EF positive), and 9 of the 10 isolates
produced MRP. In contrast only 7 of the 21 (33%) isolates from other ETs that
were examined produced MRP, including only 2 of the 8 isolates from ET 8 (4 of
which were from diseased pigs). ETs 1 and 2, which could be distinguished by the
presence ofallele 1 for esterase and allele 4forglutamatedehydrogenase, appeared
to be more virulent than other ETs. Production ofEF and MRP by these isolates
therefore may only be a marker for this virulent clone, rather than the proteins
themselves necessarily being determinants of virulence. This possibility was
suggested by Vecht and colleagues [17]. They pointed out that, in order to
determine the function ofthe proteins, it was necessary to obtain isogenic strains
that varied in their production of the proteins, and to test these strains for
virulence in pigs. Currently, irrespective of the function of EF, screening for its
production is a means of detecting isolates belonging to the virulent clone
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represented by ETs 1 and 2. Isolates from other clones that do not produce EF
however may also be capable of causing disease.
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